SAN DIEGO--(BUSINESS WIRE)--Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use of its ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Researchers did not find evidence that treatment gains ...
ROCHESTER, N.Y., Feb. 10, 2026 /PRNewswire/ -- CooperVision today announced immediate availability of its MiSight ® 1 day * myopia control contact lens in Japan, where as many as 77% of elementary ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO – CooperVision announced at Optometry’s Meeting the availability of its MiSight 1 day contact lenses in ...
A groundbreaking contact lens therapy has potential to impact the fast-growing issue of myopia (nearsightedness) among children, based on research presented at the American Academy of Optometry's 95th ...
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens
SYDNEY and LAVAL, QC, Oct. 15, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, along with BHVI, an ...
GA, UNITED STATES, February 15, 2026 / EINPresswire.com / — Myopia progression in children is commonly managed using optical interventions, yet their effectiveness often declines over time. A two-year ...
GA, UNITED STATES, February 15, 2026 /EINPresswire.com/ — Myopia progression in children is commonly managed using optical interventions, yet their effectiveness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results